Cover Image
Market Research Report

Global Biogeneric Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

Published by QYResearch Product code 691699
Published Content info 118 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Biogeneric Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
Published: September 4, 2018 Content info: 118 Pages
Description

This study researches the market size of Biogeneric Drugs, presents the global Biogeneric Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Biogeneric Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Biogeneric Drugs for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars in Europe, follows-on-biologics in US and subsequent entry biological in japan. Due to their high degree of similarity with the biological reference product, they have no clinically evidenced and meaningful differences from the reference product in terms of quality, safety or efficacy. Biogenerics drugs provide effective treatment for number of serious and life-threatening illness because of their high specificity and activity. Biogeneric are more complex compared to small molecule drugs. Their quality and safety are highly dependent on the process of production (choice of cell type, development of the genetically modified cell for production, etc.), purification and formulation. The constitution of the biogeneric drugs can be either small molecules such as human insulin or erythropoietin, or complex molecules such as monoclonal antibodies. Biogeneric drugs are increasing gaining prominence given the loss of exclusivity of big branded drugs. In Europe, biogenerics can be marketed through independent applicant following expiry of patent and market exclusivity periods of the reference product. Regulatory harmonization, naming and labelling, innovative licensure norms and route to market for the biogeneric drugs are issues expected to gain attention and traction from big drug makers in the forthcoming years.

Biogeneric drugs market is expected to increase in forecast period due to increased treatment options, value added services to care patient and healthcare community. Due to drugs introduces competition, increasing affordability of biologics which delivers saving for healthcare systems are the same factors which increase biogeneric drugs market. Introduction of affordable, high-quality biogenerics drugs improves access to life changing medicine for patients worldwide. Opportunities for generic drug products is huge but there are regulations that must be adhered to when strategizing the best ways to maximize a company's return. Government regulation may be adhere the growth of drug development investment or planning an entry into a market with a new biogeneric products.

In 2018, the global Biogeneric Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Biogeneric Drugs.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Sandoz International
  • Teva pharmaceutical industries
  • Mylan
  • 3SBio
  • Shanghai Fosun Pharmaceutical
  • Tonghua Dongbao Pharmaceutical
  • Biocon
  • Reliance life sciences
  • Probiomed
  • Biosidus
  • AMEGA Biotech
  • Celltrion
  • LG life Science
  • Dong-A Pharmaceutical

Market Segment by Product Type

  • Insulins
  • Growth Hormones
  • Monoclonal Antibodies
  • Others

Market Segment by Application

  • Hospital
  • Clinics
  • Research Centers

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Biogeneric Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Biogeneric Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biogeneric Drugs are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Major Manufacturers Covered in This Report
  • 1.3 Market Segment by Type
    • 1.3.1 Global Biogeneric Drugs Market Size Growth Rate by Type
    • 1.3.2 Insulins
  • 1.4 Market Segment by Application
    • 1.4.1 Global Biogeneric Drugs Market Share by Application (2018-2025)
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Biogeneric Drugs Market Size
    • 2.1.1 Global Biogeneric Drugs Revenue 2013-2025
    • 2.1.2 Global Biogeneric Drugs Sales 2013-2025
  • 2.2 Biogeneric Drugs Growth Rate by Regions
    • 2.2.1 Global Biogeneric Drugs Sales by Regions 2013-2018
    • 2.2.2 Global Biogeneric Drugs Revenue by Regions 2013-2018
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers

3 Market Share by Manufacturers

  • 3.1 Biogeneric Drugs Sales by Manufacturers
    • 3.1.1 Biogeneric Drugs Sales by Manufacturers 2013-2018
    • 3.1.2 Biogeneric Drugs Sales Market Share by Manufacturers 2013-2018
  • 3.2 Revenue by Manufacturers
    • 3.2.1 Biogeneric Drugs Revenue by Manufacturers (2013-2018)
    • 3.2.2 Biogeneric Drugs Revenue Share by Manufacturers (2013-2018)
    • 3.2.3 Global Biogeneric Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.3 Biogeneric Drugs Price by Manufacturers
  • 3.4 Key Manufacturers Biogeneric Drugs Plants/Factories Distribution and Area Served
  • 3.5 Date of Key Manufacturers Enter into Biogeneric Drugs Market
  • 3.6 Key Manufacturers Biogeneric Drugs Product Offered
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Sales and Revenue for Each Type
    • 4.1.1 Insulins Sales and Revenue (2013-2018)
  • 4.2 Global Biogeneric Drugs Sales Market Share by Type
  • 4.3 Global Biogeneric Drugs Revenue Market Share by Type
  • 4.4 Biogeneric Drugs Price by Type

5 Market Size by Application

  • 5.1 Overview
  • 5.2 Global Biogeneric Drugs Sales by Application

6 North America

  • 6.1 North America Biogeneric Drugs Breakdown Data by Company
  • 6.2 North America Biogeneric Drugs Breakdown Data by Type
  • 6.3 North America Biogeneric Drugs Breakdown Data by Application
  • 6.4 North America Biogeneric Drugs Breakdown Data by Countries
    • 6.4.1 North America Biogeneric Drugs Sales by Countries
    • 6.4.2 North America Biogeneric Drugs Revenue by Countries
    • 6.4.3 United States
    • 6.4.4 Canada
    • 6.4.5 Mexico

7 Europe

  • 7.1 Europe Biogeneric Drugs Breakdown Data by Company
  • 7.2 Europe Biogeneric Drugs Breakdown Data by Type
  • 7.3 Europe Biogeneric Drugs Breakdown Data by Application
  • 7.4 Europe Biogeneric Drugs Breakdown Data by Countries
    • 7.4.1 Europe Biogeneric Drugs Sales by Countries
    • 7.4.2 Europe Biogeneric Drugs Revenue by Countries
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 UK
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Biogeneric Drugs Breakdown Data by Company
  • 8.2 Asia Pacific Biogeneric Drugs Breakdown Data by Type
  • 8.3 Asia Pacific Biogeneric Drugs Breakdown Data by Application
  • 8.4 Asia Pacific Biogeneric Drugs Breakdown Data by Countries
    • 8.4.1 Asia Pacific Biogeneric Drugs Sales by Countries
    • 8.4.2 Asia Pacific Biogeneric Drugs Revenue by Countries
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 Indonesia
    • 8.4.9 Malaysia
    • 8.4.10 Philippines
    • 8.4.11 Thailand
    • 8.4.12 Vietnam

9 Central & South America

  • 9.1 Central & South America Biogeneric Drugs Breakdown Data by Company
  • 9.2 Central & South America Biogeneric Drugs Breakdown Data by Type
  • 9.3 Central & South America Biogeneric Drugs Breakdown Data by Application
  • 9.4 Central & South America Biogeneric Drugs Breakdown Data by Countries
    • 9.4.1 Central & South America Biogeneric Drugs Sales by Countries
    • 9.4.2 Central & South America Biogeneric Drugs Revenue by Countries
    • 9.4.3 Brazil

10 Middle East and Africa

  • 10.1 Middle East and Africa Biogeneric Drugs Breakdown Data by Type
  • 10.2 Middle East and Africa Biogeneric Drugs Breakdown Data by Application
  • 10.3 Middle East and Africa Biogeneric Drugs Breakdown Data by Countries
    • 10.3.1 Middle East and Africa Biogeneric Drugs Sales by Countries
    • 10.3.2 Middle East and Africa Biogeneric Drugs Revenue by Countries
    • 10.3.3 GCC Countries
    • 10.3.4 Egypt
    • 10.3.5 South Africa

11 Company Profiles

  • 11.1 Sandoz International
    • 11.1.1 Sandoz International Company Details
    • 11.1.2 Company Description and Business Overview
    • 11.1.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.1.4 Biogeneric Drugs Product Introduction
    • 11.1.5 Sandoz International Recent Development
  • 11.2 Teva pharmaceutical industries
    • 11.2.1 Teva pharmaceutical industries Company Details
    • 11.2.2 Company Description and Business Overview
    • 11.2.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.2.4 Biogeneric Drugs Product Introduction
    • 11.2.5 Teva pharmaceutical industries Recent Development
  • 11.3 Mylan
    • 11.3.1 Mylan Company Details
    • 11.3.2 Company Description and Business Overview
    • 11.3.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.3.4 Biogeneric Drugs Product Introduction
    • 11.3.5 Mylan Recent Development
  • 11.4 3SBio
    • 11.4.1 3SBio Company Details
    • 11.4.2 Company Description and Business Overview
    • 11.4.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.4.4 Biogeneric Drugs Product Introduction
    • 11.4.5 3SBio Recent Development
  • 11.5 Shanghai Fosun Pharmaceutical
    • 11.5.1 Shanghai Fosun Pharmaceutical Company Details
    • 11.5.2 Company Description and Business Overview
    • 11.5.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.5.4 Biogeneric Drugs Product Introduction
    • 11.5.5 Shanghai Fosun Pharmaceutical Recent Development
  • 11.6 Tonghua Dongbao Pharmaceutical
    • 11.6.1 Tonghua Dongbao Pharmaceutical Company Details
    • 11.6.2 Company Description and Business Overview
    • 11.6.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.6.4 Biogeneric Drugs Product Introduction
    • 11.6.5 Tonghua Dongbao Pharmaceutical Recent Development
  • 11.7 Biocon
    • 11.7.1 Biocon Company Details
    • 11.7.2 Company Description and Business Overview
    • 11.7.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.7.4 Biogeneric Drugs Product Introduction
    • 11.7.5 Biocon Recent Development
  • 11.8 Reliance life sciences
    • 11.8.1 Reliance life sciences Company Details
    • 11.8.2 Company Description and Business Overview
    • 11.8.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.8.4 Biogeneric Drugs Product Introduction
    • 11.8.5 Reliance life sciences Recent Development
  • 11.9 Probiomed
    • 11.9.1 Probiomed Company Details
    • 11.9.2 Company Description and Business Overview
    • 11.9.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.9.4 Biogeneric Drugs Product Introduction
    • 11.9.5 Probiomed Recent Development
  • 11.10 Biosidus
    • 11.10.1 Biosidus Company Details
    • 11.10.2 Company Description and Business Overview
    • 11.10.3 Sales, Revenue and Market Share of Biogeneric Drugs
    • 11.10.4 Biogeneric Drugs Product Introduction
    • 11.10.5 Biosidus Recent Development
  • 11.11 AMEGA Biotech

12 Value Chain and Sales Channels Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Sales Channels Analysis
    • 12.2.1 Biogeneric Drugs Sales Channels
    • 12.2.2 Biogeneric Drugs Distributors
  • 12.3 Biogeneric Drugs Customers

13 Market Forecast

  • 13.1 Global Biogeneric Drugs Sales and Revenue Forecast 2018-2025
  • 13.2 Global Biogeneric Drugs Sales Forecast by Type
  • 13.3 Global Biogeneric Drugs Sales Forecast by Application
  • 13.4 Biogeneric Drugs Forecast by Regions
    • 13.4.1 Global Biogeneric Drugs Sales Forecast by Regions 2018-2025
    • 13.4.2 Global Biogeneric Drugs Revenue Forecast by Regions 2018-2025
  • 13.5 North America Market Forecast
    • 13.5.1 North America Biogeneric Drugs Forecast by Countries 2018-2025
    • 13.5.2 United States
    • 13.5.3 Canada
    • 13.5.4 Mexico
  • 13.6 Europe Market Forecast
    • 13.6.1 Europe Biogeneric Drugs Forecast by Countries 2018-2025
    • 13.6.2 Germany
    • 13.6.3 France
    • 13.6.4 UK
    • 13.6.5 Italy
    • 13.6.6 Russia
  • 13.7 Asia Pacific Market Forecast
    • 13.7.1 Asia Pacific Biogeneric Drugs Sales Forecast by Countries 2018-2025
    • 13.7.2 China
    • 13.7.3 Japan
    • 13.7.4 Korea
    • 13.7.5 India
    • 13.7.6 Australia
    • 13.7.7 Indonesia
    • 13.7.8 Thailand
    • 13.7.9 Malaysia
    • 13.7.10 Philippines
    • 13.7.11 Vietnam
  • 13.8 Central & South America Market Forecast
    • 13.8.1 Central & South America Biogeneric Drugs Sales Forecast by Countries 2018-2025
    • 13.8.2 Brazil
  • 13.9 Middle East and Africa Market Forecast
    • 13.9.1 Middle East and Africa Biogeneric Drugs Sales Forecast by Countries 2018-2025
    • 13.9.2 GCC Countries
    • 13.9.3 Egypt
    • 13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables and Figures

  • Figure Biogeneric Drugs Product Picture
  • Table Biogeneric Drugs Key Market Segments
  • Table Major Manufacturers Biogeneric Drugs Covered in This Report
  • Table Global Biogeneric Drugs Market Size Growth Rate by Type 2018-2025 (K MT) & (Million US$)
  • Figure Global Biogeneric Drugs Sales Market Shar by Type 2013-2025
  • Figure Insulins Figures
  • Table Major Manufacturers of Insulins
  • Figure Growth Hormones Figures
  • Table Major Manufacturers of Growth Hormones
  • Figure Monoclonal Antibodies Figures
  • Table Global Biogeneric Drugs Market Share by Application 2018-2025 (K MT)
  • Figure Biogeneric Drugs Report Years Considered
  • Figure Global Biogeneric Drugs Market Size 2013-2025 (Million US$)
  • Figure Global Biogeneric Drugs Sales 2013-2018 (K MT)
  • Table Global Biogeneric Drugs Market Size by Regions 2013-2018 (K MT) & (Million US$)
  • Table Global Biogeneric Drugs Sales by Regions 2013-2018 (K MT)
  • Table Global Biogeneric Drugs Sales Market Share by Regions 2013-2018
  • Figure Global Biogeneric Drugs Sales Market Share by Regions 2013-2018
  • Figure Global Biogeneric Drugs Sales Market Share by Regions in 2018
  • Table Global Biogeneric Drugs Revenue by Regions 2013-2018 (Million US$)
  • Table Global Biogeneric Drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Biogeneric Drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Biogeneric Drugs Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Biogeneric Drugs Sales by Manufacturers (2013-2018) (K MT)
  • Table Global Biogeneric Drugs Sales Share by Manufacturers (2013-2018)
  • Figure Global Biogeneric Drugs Sales Share by Manufacturers in 2018
  • Table Biogeneric Drugs Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Biogeneric Drugs Revenue Share by Manufacturers (2013-2018)
  • Figure Biogeneric Drugs Value Share by Manufacturers in 2018
  • Table Global Biogeneric Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Biogeneric Drugs Price (2013-2018) (USD/MT)
  • Table Key Manufacturers Biogeneric Drugs Plants/Factories Distribution
  • Table Key Manufacturers Biogeneric Drugs Area Served
  • Table Date of Key Manufacturers Enter into Biogeneric Drugs Market
  • Table Key Manufacturers Biogeneric Drugs Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Insulins Sales and Revenue (2013-2018) (K MT) & (Million US$)
  • Table Global Biogeneric Drugs Sales by Type (2013-2018) (K MT)
  • Table Global Biogeneric Drugs Sales Share by Type (2013-2018)
  • Figure Global Biogeneric Drugs Sales Market Share by Type (2013-2018)
  • Figure Global Biogeneric Drugs Sales Market Share by Type in 2017
  • Table Global Biogeneric Drugs Revenue by Type (2013-2018) (Million US$)
  • Table Global Biogeneric Drugs Revenue Share by Type (2013-2018)
  • Figure Global Biogeneric Drugs Revenue Market Share by Type (2013-2018)
  • Figure Global Biogeneric Drugs Revenue Market Share by Type in 2017
  • Table Biogeneric Drugs Price by Type 2013-2018 (USD/MT)
  • Table Global Biogeneric Drugs Sales by Application (2013-2018) (K MT)
  • Table Global Biogeneric Drugs Sales Share by Application (2013-2018)
  • Figure Global Sales Biogeneric Drugs Market Share by Application (2013-2018)
  • Figure Global Sales Biogeneric Drugs Market Share by Application in 2017
  • Figure North America Biogeneric Drugs Sales Growth Rate 2013-2018 (K MT)
  • Figure North America Biogeneric Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Biogeneric Drugs Sales by Company (2013-2018) (K MT)
  • Table North America Biogeneric Drugs Sales Market Share by Company (2013-2018)
  • Figure North America Biogeneric Drugs Sales Market Share by Company in 2018
  • Table North America Biogeneric Drugs Sales by Type (2013-2018) (K MT)
  • Table North America Biogeneric Drugs Sales Market Share by Type (2013-2018)
  • Figure North America Biogeneric Drugs Market Share by Type in 2018
  • Table North America Biogeneric Drugs Sales by Application (2013-2018) (K MT)
  • Table North America Biogeneric Drugs Sales Market Share by Application (2013-2018)
  • Figure North America Biogeneric Drugs Market Share by Application in 2018
  • Table North America Biogeneric Drugs Sales by Countries (2013-2018) (K MT)
  • Table North America Biogeneric Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Biogeneric Drugs Sales Market Share by Countries
  • Table North America Biogeneric Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table North America Biogeneric Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Biogeneric Drugs Revenue Market Share by Countries
  • Figure United States Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Canada Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Mexico Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Europe Biogeneric Drugs Sales Growth Rate 2013-2018 (K MT)
  • Figure Europe Biogeneric Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Biogeneric Drugs Sales by Company (2013-2018) (K MT)
  • Table Europe Biogeneric Drugs Sales Market Share by Company (2013-2018)
  • Figure Europe Biogeneric Drugs Sales Market Share by Company in 2018
  • Table Europe Biogeneric Drugs Sales by Type (2013-2018) (K MT)
  • Table Europe Biogeneric Drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Biogeneric Drugs Market Share by Type
  • Table Europe Biogeneric Drugs Sales by Application (2013-2018) (K MT)
  • Table Europe Biogeneric Drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Biogeneric Drugs Market Share by Application
  • Table Europe Biogeneric Drugs Sales by Countries (2013-2018) (K MT)
  • Table Europe Biogeneric Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Biogeneric Drugs Sales Market Share by Countries
  • Table Europe Biogeneric Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Biogeneric Drugs Revenue Market Share by Countries (2013-2018)
  • Figure Europe Biogeneric Drugs Revenue Market Share by Countries in 2018
  • Figure Germany Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure France Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure UK Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Italy Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Russia Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Asia Pacific Biogeneric Drugs Sales Growth Rate 2013-2018 (K MT)
  • Figure Asia Pacific Biogeneric Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Biogeneric Drugs Sales by Company (2013-2018) (K MT)
  • Table Asia Pacific Biogeneric Drugs Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Biogeneric Drugs Sales Market Share by Company in 2018
  • Table Asia Pacific Biogeneric Drugs Sales by Type (2013-2018) (K MT)
  • Table Asia Pacific Biogeneric Drugs Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Biogeneric Drugs Market Share by Type in 2018
  • Table Asia Pacific Biogeneric Drugs Sales by Application (2013-2018) (K MT)
  • Table Asia Pacific Biogeneric Drugs Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Biogeneric Drugs Market Share by Application in 2018
  • Table Asia Pacific Biogeneric Drugs Sales by Countries (2013-2018) (K MT)
  • Table Asia Pacific Biogeneric Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Biogeneric Drugs Sales Market Share by Countries
  • Table Asia Pacific Biogeneric Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Biogeneric Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Biogeneric Drugs Revenue Market Share by Countries
  • Figure China Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure China Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Japan Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Korea Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure India Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Australia Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Indonesia Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Malaysia Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Philippines Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Thailand Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Vietnam Biogeneric Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Biogeneric Drugs Sales Growth Rate 2013-2018 (K MT)
  • Figure Central & South America Biogeneric Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Biogeneric Drugs Sales by Company (2013-2018) (K MT)
  • Table Central & South America Biogeneric Drugs Sales Market Share by Company (2013-2018)
  • Figure Central & South America Biogeneric Drugs Sales Market Share by Company in 2018
  • Table Central & South America Biogeneric Drugs Sales by Type (2013-2018) (K MT)
  • Table Central & South America Biogeneric Drugs Sales Market Share by Type (2013-2018)
  • Figure Central & South America Biogeneric Drugs Market Share by Type in 2018
  • Table Central & South America Biogeneric Drugs Sales by Application (2013-2018) (K MT)
  • Table Central & South America Biogeneric Drugs Sales Market Share by Application (2013-2018)
  • Figure Central & South America Biogeneric Drugs Market Share by Application in 2018
  • Table Central & South America Biogeneric Drugs Sales by Countries (2013-2018) (K MT)
  • Table Central & South America Biogeneric Drugs Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Biogeneric Drugs Sales Market Share by Countries in 2018
  • Table Central & South America Biogeneric Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Biogeneric Drugs Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Biogeneric Drugs Revenue Market Share by Countries in 2018
  • Figure Brazil Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Brazil Biogeneric Drugs Revenue Growth Rate (2013-2018) (K MT)
  • Figure Middle East and Africa Biogeneric Drugs Sales Growth Rate 2013-2018 (K MT)
  • Figure Middle East and Africa Biogeneric Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Biogeneric Drugs Sales by Type (2013-2018) (K MT)
  • Table Middle East and Africa Biogeneric Drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Biogeneric Drugs Market Share by Type
  • Table Middle East and Africa Biogeneric Drugs Sales by Application (2013-2018) (K MT)
  • Table Middle East and Africa Biogeneric Drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Biogeneric Drugs Market Share by Application
  • Table Middle East and Africa Biogeneric Drugs Sales by Countries (2013-2018) (K MT)
  • Table Middle East and Africa Biogeneric Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Biogeneric Drugs Sales Market Share by Countries
  • Table Middle East and Africa Biogeneric Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Biogeneric Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Biogeneric Drugs Revenue Market Share by Countries
  • Figure GCC Countries Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure GCC Countries Biogeneric Drugs Revenue Growth Rate (2013-2018) (K MT)
  • Figure Egypt Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure Egypt Biogeneric Drugs Revenue Growth Rate (2013-2018) (K MT)
  • Figure South Africa Biogeneric Drugs Sales Growth Rate (2013-2018) (K MT)
  • Figure South Africa Biogeneric Drugs Revenue Growth Rate (2013-2018) (K MT)
  • Table Sandoz International Company Details
  • Table Sandoz International Description and Business Overview
  • Table Sandoz International Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Sandoz International Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Sandoz International Biogeneric Drugs Sales Market Share in Global Market
  • Table Sandoz International Recent Development
  • Table Teva pharmaceutical industries Company Details
  • Table Teva pharmaceutical industries Description and Business Overview
  • Table Teva pharmaceutical industries Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Teva pharmaceutical industries Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Teva pharmaceutical industries Biogeneric Drugs Sales Market Share in Global Market
  • Table Teva pharmaceutical industries Recent Development
  • Table Mylan Company Details
  • Table Mylan Description and Business Overview
  • Table Mylan Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Mylan Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Mylan Biogeneric Drugs Sales Market Share in Global Market
  • Table Mylan Recent Development
  • Table 3SBio Company Details
  • Table 3SBio Description and Business Overview
  • Table 3SBio Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table 3SBio Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table 3SBio Biogeneric Drugs Sales Market Share in Global Market
  • Table 3SBio Recent Development
  • Table Shanghai Fosun Pharmaceutical Company Details
  • Table Shanghai Fosun Pharmaceutical Description and Business Overview
  • Table Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales Market Share in Global Market
  • Table Shanghai Fosun Pharmaceutical Recent Development
  • Table Tonghua Dongbao Pharmaceutical Company Details
  • Table Tonghua Dongbao Pharmaceutical Description and Business Overview
  • Table Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales Market Share in Global Market
  • Table Tonghua Dongbao Pharmaceutical Recent Development
  • Table Biocon Company Details
  • Table Biocon Description and Business Overview
  • Table Biocon Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Biocon Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Biocon Biogeneric Drugs Sales Market Share in Global Market
  • Table Biocon Recent Development
  • Table Reliance life sciences Company Details
  • Table Reliance life sciences Description and Business Overview
  • Table Reliance life sciences Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Reliance life sciences Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Reliance life sciences Biogeneric Drugs Sales Market Share in Global Market
  • Table Reliance life sciences Recent Development
  • Table Probiomed Company Details
  • Table Probiomed Description and Business Overview
  • Table Probiomed Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Probiomed Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Probiomed Biogeneric Drugs Sales Market Share in Global Market
  • Table Probiomed Recent Development
  • Table Biosidus Company Details
  • Table Biosidus Description and Business Overview
  • Table Biosidus Biogeneric Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2013-2018)
  • Table Biosidus Biogeneric Drugs Sales Growth Rate (2013-2018)
  • Table Biosidus Biogeneric Drugs Sales Market Share in Global Market
  • Table Biosidus Recent Development
  • Table AMEGA Biotech Company Details
  • Figure Biogeneric Drugs Value Chain
  • Table Biogeneric Drugs Distributors List
  • Table Biogeneric Drugs Customers List
  • Table Global Biogeneric Drugs Sales Forecast 2018-2025 (K MT) & (Million US$)
  • Figure Global Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Global Biogeneric Drugs Revenue Forecast 2018-2025 (Million US$)
  • Table Global Biogeneric Drugs Sales Forecast by Type 2018-2025 (K MT)
  • Figure Global Biogeneric Drugs Sales Forecast by Type 2018-2025 (K MT)
  • Figure Global Biogeneric Drugs Sales Market Share Forecast by Type 2018-2025
  • Table Global Biogeneric Drugs Sales Forecast by Application 2018-2025 (K MT)
  • Figure Global Biogeneric Drugs Sales Forecast by Application 2018-2025 (K MT)
  • Figure Global Biogeneric Drugs Sales Market Share Forecast by Application 2018-2025
  • Table Global Biogeneric Drugs Sales Forecast by Regions 2018-2025 (K MT)
  • Figure Global Biogeneric Drugs Sales Forecast by Regions 2018-2025 (K MT)
  • Figure Global Biogeneric Drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Global Biogeneric Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Biogeneric Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Biogeneric Drugs Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Biogeneric Drugs Sales Forecast by Countries 2018-2025 (K MT)
  • Table North America Biogeneric Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table North America Biogeneric Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Biogeneric Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Canada Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure MexicoBiogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Table Europe Biogeneric Drugs Sales Forecast by Countries 2018-2025 (K MT)
  • Table Europe Biogeneric Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Biogeneric Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Biogeneric Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure France Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure UK Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Italy Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Russia Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Table Asia Pacific Biogeneric Drugs Sales Forecast by Countries 2018-2025 (K MT)
  • Table Asia Pacific Biogeneric Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Biogeneric Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Biogeneric Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Japan Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Korea Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure India Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Australia Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Indonesia Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Thailand Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Malaysia Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Philippines Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Figure Vietnam Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Table Central & South America Biogeneric Drugs Sales Forecast by Countries 2018-2025 (K MT)
  • Table Central & South America Biogeneric Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Biogeneric Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Biogeneric Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Biogeneric Drugs Sales Forecast 2018-2025 (K MT)
  • Table Middle East and Africa Biogeneric Drugs Sales Forecast by Regions 2018-2025 (K MT)
  • Table Middle East and Africa Biogeneric Drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Biogeneric Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Biogeneric Drugs Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Biogeneric Drugs Sales Growth Rate (2016-2025) (K MT)
  • Figure Egypt Biogeneric Drugs Sales Growth Rate (2016-2025) (K MT)
  • Figure South Africa Biogeneric Drugs Sales Growth Rate (2016-2025) (K MT)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
Back to Top